Mohammadreza Taban Sadeghi
Overview
Explore the profile of Mohammadreza Taban Sadeghi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toufan M, Khezerlouy-Aghdam N, Sakha H, Separham A, Pakdel S, Shahverdi M, et al.
Int J Cardiovasc Imaging
. 2024 Jul;
40(10):2069-2075.
PMID: 39073553
Left atrium longitudinal strain (LAS) with speckle tracking method has been proposed as a non-invasive method for the assessment of left ventricular filling pressure and diastolic dysfunction. This study aimed...
2.
Chenaghlou M, Mahzoon F, Hamzehzadeh S, Norouzi A, Sahrai H, Mohammadi N, et al.
BMC Cardiovasc Disord
. 2024 Jan;
24(1):30.
PMID: 38172681
Background: Recent studies have shown that increases in serum UA levels are associated with adverse clinical outcomes in patients with chronic heart failure (CHF); the aim of this study was...
3.
Ghafouri Asbagh A, Taban Sadeghi M, Ramazanilar P, Nateghian H
ESC Heart Fail
. 2023 Jul;
10(5):2837-2842.
PMID: 37408169
Aims: Heart failure (HF) is usually associated with complications of other organs. Renal impairment is seen in a significant proportion of HF patients and is characterized by worsening renal function...
4.
Asghari E, Gholizadeh L, Kazami L, Taban Sadeghi M, Separham A, Khezerloy-Aghdam N
BMC Cardiovasc Disord
. 2022 Nov;
22(1):508.
PMID: 36443668
Background: Women are more likely to delay medical help-seeking for ACS symptoms. Understanding patients' experience of the symptoms and their response is essential in improving help-seeking behaviors and timely diagnosis...
5.
Roshanravan N, Koche Ghazi M, Ghaffari S, Naemi M, Mesri Alamdari N, Namazi Shabestari A, et al.
Nutr Metab Cardiovasc Dis
. 2022 Apr;
32(6):1528-1537.
PMID: 35365371
Background And Aims: Atherosclerosis as a chronic inflammatory disorder of the arterial wall is the main leading cause of the cardiovascular disease (CVD). Caspase-dependent pyroptosis plays a pivotal role in...
6.
Koche Ghazi M, Ghaffari S, Naemi M, Salehi R, Taban Sadeghi M, Barati M, et al.
J Cardiovasc Thorac Res
. 2022 Jan;
13(4):314-319.
PMID: 35047136
Atherosclerosis and related cardiovascular diseases (CVDs) are the major causes of mortality worldwide. The available reports regarding the effects of selenium (Se) supplementation in the realm of atherosclerosis have been...
7.
Taban Sadeghi M, Esgandarian I, Nouri-Vaskeh M, Golmohammadi A, Rahvar N, Teimourizad A
Med Pharm Rep
. 2020 Nov;
93(4):351-356.
PMID: 33225260
Background: Pro-inflammatory signaling is mediated by a variety of inflammatory mediators which can cause myocardial apoptosis, hypertrophia, and fibrosis, and also ultimately lead to adverse cardiac remodeling. This study aimed...
8.
Soroureddin Z, Nouri-Vaskeh M, Maleki M, Baghbanzadeh A, Hajiasgharzadeh K, Taban Sadeghi M, et al.
Life Sci
. 2020 May;
253:117720.
PMID: 32360620
Despite considerable progressions, cardiovascular disease (CVD) is still one of the major causes of mortality around the world, indicates an important and unmet clinical need. Recently, extensive studies have been...
9.
Taban Sadeghi M, Soroureddin Z, Nouri-Vaskeh M, Nazarpoori P, Aghayari Sheikh Neshin S
BMC Res Notes
. 2019 Dec;
12(1):824.
PMID: 31870432
Objective: Absence of nocturnal blood pressure (BP) dipping is associated with poor health outcomes, including increased mortality. Non-dipper BP seems to be a predictor of cardiovascular damage in hypertensive patients....
10.
Abedimanesh S, Bathaie S, Ostadrahimi A, Jafarabadi M, Taban Sadeghi M
Food Funct
. 2019 Nov;
10(11):7461-7475.
PMID: 31667483
Background And Purpose: Molecular mechanisms of atherogenesis are considered to be emerging therapeutic targets for atherosclerosis prevention. Cell and animal studies have shown that crocetin can decelerate atherogenesis. However, the...